3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe

OncologyMedicineHealth Policy
Written by Kerrington .
Episode 3.77 Show Notes

Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases.

Kerrington .
Previous

3.78 Astronomy, Being a Scientist, and the Culture of the Academy with Dr. Avi Loeb
Next

3.76 COVID-19 Transmission in Schools with Dr. Christopher Whaley and Dr. Neeraj Sood